LONDON, June 04, 2026 (GLOBE NEWSWIRE) -- DaltonTx, the intelligence backbone for modern drug discovery: connecting AI, human expertise and experimental data, today announced the launch of Dalton, its ...
Dr Garry Pairaudeau, DaltonTx's CEO and co-founder. Just a few months after emerging from stealth with a mission to build adaptive AI platforms for drug discovery, UK start-up DaltonTx has officially ...
Dalton is a drug discovery platform integrating agentic AI, human expertise, and experimental data, into one continuous learning engine Announces collaboration with Sygnature Discovery, a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results